Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-Pen for hypoglycemia rescue in T1D
NCT02423980Phase 2Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- Apr 2015
- Primary completion
- May 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon in hypoglycemia, sponsored by Xeris Biopharma Holdings, Inc.. Started Apr 2015; status: completed.
02
Drugs
glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02423980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423980.